27 filings
EFFECT
PBM
Psyence Biomedical Ltd.
15 May 24
Notice of effectiveness
12:15am
F-1/A
PBM
Psyence Biomedical Ltd.
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
PBM
Psyence Biomedical Ltd.
18 Apr 24
Registration statement (foreign) (amended)
6:03am
6-K
PBM
Psyence Biomedical Ltd.
15 Mar 24
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
5:10pm
6-K
PBM
Psyence Biomedical Ltd.
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
F-1
5a4ioj9
9 Feb 24
Registration statement (foreign)
4:09pm
20-F
jatqx9y zp
31 Jan 24
Annual report (foreign)
5:05pm
CERT
bkni8ial6rl3kf3t kuz
26 Jan 24
Certification of approval for exchange listing
12:00am
8-A12B
owzg7w3eb4458wl1sg67
25 Jan 24
Registration of securities on exchange
5:24pm
425
5oygg118
22 Jan 24
Business combination disclosure
9:53pm
425
1bcv4 x3spjjgc7t8h
17 Jan 24
Business combination disclosure
6:00am
425
4n9b97gbt9 0ayyxsjri
15 Nov 23
Business combination disclosure
5:15pm
424B3
yyav gye0yn31
15 Nov 23
Prospectus supplement
4:28pm
SEC STAFF
swrlhxl3v
15 Nov 23
SEC staff action: Order
12:00am
F-4/A
tm20amh xm89xwkoa
13 Nov 23
Registration of securities (foreign) (amended)
3:59pm
F-4/A
fdyem 6w2t
13 Nov 23
Registration of securities (foreign) (amended)
9:27am
CORRESP
gy82p6rvll2
13 Nov 23
Correspondence with SEC
12:00am
EFFECT
w9vo ltatqqh4hpqv1
13 Nov 23
Notice of effectiveness
12:00am
F-4/A
zckhrprq8uyh9tk8
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
CORRESP
hmwdyrintf7
3 Nov 23
Correspondence with SEC
12:00am